| John Cecil Boston, DO | |
|
950 E Bogard Rd, Suite 228, Wasilla, AK 99654-7184 | |
| (907) 376-2868 | |
| (907) 376-2811 |
| Full Name | John Cecil Boston |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 23 Years |
| Location | 950 E Bogard Rd, Wasilla, Alaska |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982666137 | NPI | - | NPPES |
| MD2914 | Medicaid | AK | |
| 610518000 | Other | AK | DEPARTMENT OF LABOR |
| DC8103 | Other | AK | MEDICARE RAILROAD |
| 201322021 | Other | AK | TAX ID |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 5285 (Alaska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mat-su Regional Medical Center | Palmer, AK | Hospital |
| Providence Alaska Medical Center | Anchorage, AK | Hospital |
| Central Peninsula General Hospital | Soldotna, AK | Hospital |
| Maple Springs Of Wasilla | Wasilla, AK | Nursing home |
| Prestige Care & Rehab Center Of Anchorage | Anchorage, AK | Nursing home |
| Maple Springs Of Palmer | Palmer, AK | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Alaska Hospitalist Group Llc | 6507755964 | 84 |
News Archive
Europe's largest meeting for the science and treatment of disorders of the brain, the 28th ECNP Congress of the European College of Neuropsychopharmacology will take place at the Amsterdam RAI from 29 August to 1 September 2015.
NanoBio Corporation today announced compelling preclinical data for NB-201, a nanoemulsion-based topical lotion for the treatment of burn wounds. In preclinical studies, NB-201 dramatically reduced the severity of burn wound infections as well as inflammation following thermal injuries. The research was conducted at the University of Michigan Medical School in Ann Arbor as a collaborative effort between the University and NanoBio.
Brothers and sisters as well as parents of infants born with severe, life-threatening abnormalities of the left side of the heart should be screened for less severe, but related, heart problems, said researchers at Baylor College of Medicine in Houston.
Is the current American drug overdose epidemic an isolated phenomenon? Have other high-income countries experienced similar increases in drug overdose mortality, or are they likely to going forward? A new study published in Population and Development Review addresses these questions.
A new study published in the scientific journal Proceedings of the National Academy of Sciences of the United States of America sheds new light on a well-known mechanism required for the immune response. Researchers at the IRCM, led by Tarik Möröy, PhD, identified a protein that controls the activity of the p53 tumour suppressor protein known as the "guardian of the genome".
› Verified 5 days ago
| Entity Name | Mat Su Valley Medical Center Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912950148 PECOS PAC ID: 5698686475 Enrollment ID: O20040123000583 |
News Archive
Europe's largest meeting for the science and treatment of disorders of the brain, the 28th ECNP Congress of the European College of Neuropsychopharmacology will take place at the Amsterdam RAI from 29 August to 1 September 2015.
NanoBio Corporation today announced compelling preclinical data for NB-201, a nanoemulsion-based topical lotion for the treatment of burn wounds. In preclinical studies, NB-201 dramatically reduced the severity of burn wound infections as well as inflammation following thermal injuries. The research was conducted at the University of Michigan Medical School in Ann Arbor as a collaborative effort between the University and NanoBio.
Brothers and sisters as well as parents of infants born with severe, life-threatening abnormalities of the left side of the heart should be screened for less severe, but related, heart problems, said researchers at Baylor College of Medicine in Houston.
Is the current American drug overdose epidemic an isolated phenomenon? Have other high-income countries experienced similar increases in drug overdose mortality, or are they likely to going forward? A new study published in Population and Development Review addresses these questions.
A new study published in the scientific journal Proceedings of the National Academy of Sciences of the United States of America sheds new light on a well-known mechanism required for the immune response. Researchers at the IRCM, led by Tarik Möröy, PhD, identified a protein that controls the activity of the p53 tumour suppressor protein known as the "guardian of the genome".
› Verified 5 days ago
| Entity Name | Alaska Hospitalist Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831296995 PECOS PAC ID: 6507755964 Enrollment ID: O20040312001148 |
News Archive
Europe's largest meeting for the science and treatment of disorders of the brain, the 28th ECNP Congress of the European College of Neuropsychopharmacology will take place at the Amsterdam RAI from 29 August to 1 September 2015.
NanoBio Corporation today announced compelling preclinical data for NB-201, a nanoemulsion-based topical lotion for the treatment of burn wounds. In preclinical studies, NB-201 dramatically reduced the severity of burn wound infections as well as inflammation following thermal injuries. The research was conducted at the University of Michigan Medical School in Ann Arbor as a collaborative effort between the University and NanoBio.
Brothers and sisters as well as parents of infants born with severe, life-threatening abnormalities of the left side of the heart should be screened for less severe, but related, heart problems, said researchers at Baylor College of Medicine in Houston.
Is the current American drug overdose epidemic an isolated phenomenon? Have other high-income countries experienced similar increases in drug overdose mortality, or are they likely to going forward? A new study published in Population and Development Review addresses these questions.
A new study published in the scientific journal Proceedings of the National Academy of Sciences of the United States of America sheds new light on a well-known mechanism required for the immune response. Researchers at the IRCM, led by Tarik Möröy, PhD, identified a protein that controls the activity of the p53 tumour suppressor protein known as the "guardian of the genome".
› Verified 5 days ago
| Entity Name | Boston Consults Of Alaska, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538842778 PECOS PAC ID: 3375998511 Enrollment ID: O20231009002013 |
News Archive
Europe's largest meeting for the science and treatment of disorders of the brain, the 28th ECNP Congress of the European College of Neuropsychopharmacology will take place at the Amsterdam RAI from 29 August to 1 September 2015.
NanoBio Corporation today announced compelling preclinical data for NB-201, a nanoemulsion-based topical lotion for the treatment of burn wounds. In preclinical studies, NB-201 dramatically reduced the severity of burn wound infections as well as inflammation following thermal injuries. The research was conducted at the University of Michigan Medical School in Ann Arbor as a collaborative effort between the University and NanoBio.
Brothers and sisters as well as parents of infants born with severe, life-threatening abnormalities of the left side of the heart should be screened for less severe, but related, heart problems, said researchers at Baylor College of Medicine in Houston.
Is the current American drug overdose epidemic an isolated phenomenon? Have other high-income countries experienced similar increases in drug overdose mortality, or are they likely to going forward? A new study published in Population and Development Review addresses these questions.
A new study published in the scientific journal Proceedings of the National Academy of Sciences of the United States of America sheds new light on a well-known mechanism required for the immune response. Researchers at the IRCM, led by Tarik Möröy, PhD, identified a protein that controls the activity of the p53 tumour suppressor protein known as the "guardian of the genome".
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John Cecil Boston, DO Po Box 871830, Wasilla, AK 99687-1830 Ph: (907) 376-2868 | John Cecil Boston, DO 950 E Bogard Rd, Suite 228, Wasilla, AK 99654-7184 Ph: (907) 376-2868 |
News Archive
Europe's largest meeting for the science and treatment of disorders of the brain, the 28th ECNP Congress of the European College of Neuropsychopharmacology will take place at the Amsterdam RAI from 29 August to 1 September 2015.
NanoBio Corporation today announced compelling preclinical data for NB-201, a nanoemulsion-based topical lotion for the treatment of burn wounds. In preclinical studies, NB-201 dramatically reduced the severity of burn wound infections as well as inflammation following thermal injuries. The research was conducted at the University of Michigan Medical School in Ann Arbor as a collaborative effort between the University and NanoBio.
Brothers and sisters as well as parents of infants born with severe, life-threatening abnormalities of the left side of the heart should be screened for less severe, but related, heart problems, said researchers at Baylor College of Medicine in Houston.
Is the current American drug overdose epidemic an isolated phenomenon? Have other high-income countries experienced similar increases in drug overdose mortality, or are they likely to going forward? A new study published in Population and Development Review addresses these questions.
A new study published in the scientific journal Proceedings of the National Academy of Sciences of the United States of America sheds new light on a well-known mechanism required for the immune response. Researchers at the IRCM, led by Tarik Möröy, PhD, identified a protein that controls the activity of the p53 tumour suppressor protein known as the "guardian of the genome".
› Verified 5 days ago
David L Barnes, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3719 E Meridian Loop Ste A, Wasilla, AK 99654 Phone: 907-376-2868 Fax: 907-376-2811 | |
Dr. Loetta Mae Horswill-woods, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3719 E Meridian Loop, Suite F, Wasilla, AK 99654 Phone: 907-373-5940 Fax: 907-373-5947 | |
Samuel Lee Abbate, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 3331 E Meridian Park Loop, Wasilla, AK 99654 Phone: 907-357-2332 | |
Lisa M Cooney, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1751 E Gardner Way, Suite E, Wasilla, AK 99654 Phone: 907-376-1633 Fax: 907-376-7864 | |
Richard J Zajac, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 950 Bogard Rd, 207, Wasilla, AK 99654 Phone: 907-357-9444 | |
Dr. Carole Suzanne Ruegsegger, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 3750 E Country Field Cir, Unit B, Wasilla, AK 99654 Phone: 907-357-7240 Fax: 907-357-7241 |